Niagen Bioscience Acquires Existing Core Nicotinamide Riboside (NR) Patent Portfolio from Queen’s University Belfast
Intellectual Property News
The Company's intellectual property estate includes more than 90 issued and pending patents worldwide across NR and other NAD+ precursors, including ...
